According to Ginestier et al. (2007), the expression of ALDH, a cluster of enzymatic molecules that have an active role in the metabolism of aldehyde derivatives, was utilized as a marker of unfavorable results in BC patients, as it was correlated with enhanced oncogenic capabilities and resistance to antineoplastic molecules. Here, LDHA is linked to breast cancer.